美国老年住院患者多重耐药菌感染的死亡、住院时长与医疗费用
BACKGROUND: This study reports estimates of the healthcare costs, length of stay, and mortality associated with infections due to multidrug-resistant bacteria among elderly individuals in the United States.…
核心结论
- 预防多重耐药菌感染可挽救大量生命并节省医疗资源。
研究设计与样本
- 对美国退伍军人事务部医疗系统2007年1月至2018年12月≥65岁住院患者进行回顾性队列分析。
- 采用多变量回归模型估计归因费用与死亡,构建多状态模型估计归因住院时长,并乘以2017年全国住院病例数。
主要发现
- 医院起病侵袭性感染归因死亡率从MRSA的14.2%(95%CI 12.2-16.2%)到碳青霉烯耐药不动杆菌的24.1%(95%CI 12.1-36.0%)。
临床怎么用
- 提示临床应重视老年住院患者多重耐药菌感染的预防,尤其是医院起病侵袭性感染。
- 可参考归因费用与死亡率数据评估感染防控投入的潜在收益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study reports estimates of the healthcare costs, length of stay, and mortality associated with infections due to multidrug-resistant bacteria among elderly individuals in the United States. METHODS: We conducted a retrospective cohort analysis of patients aged ≥65 admitted for inpatient stays in the Department of Veterans Affairs healthcare system between 1/2007-12/2018. We identified those with positive cultures for multidrug-resistant bacteria and matched each infected patient to ≤10 control patients. We then performed multivariable regression models to estimate the attributable cost and mortality due to the infection. We also constructed multistate models to estimate the attributable length of stay due to the infection. Finally, we multiplied these pathogen-specific attributable cost, length of stay, and mortality estimates by national case counts from hospitalized patients in 2017. RESULTS: Our cohort consisted of 87 509 patients with infections and 835 048 matched controls. Costs were higher for hospital-onset invasive infections, with attributable costs ranging from $22 293 (95% confidence interval: $19 101-$24 485) for methicillin-resistant Staphylococcus aureus (MRSA) to $57 390 ($34 070-$80 710) for carbapenem-resistant (CR) Acinetobacter. Similarly, for hospital-onset invasive infections, attributable mortality estimates ranged from 14.2% (12.2-16.2%) for MRSA to 24.1% (12.1-36.0%) for CR Acinetobacter. The aggregate cost of these infections was an estimated $1.9 billion ($1.3 billion-$2.5 billion) with 11 852 (8719-14 985) deaths and 448 224 (354 513-541 934) inpatient days in 2017. CONCLUSIONS: Efforts to prevent these infections due to multidrug-resistant bacteria could save a significant number of lives and healthcare resources.
引用
- Nelson RE, Hyun D, Jezek A, et al. Mortality, Length of Stay, and Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Elderly Hospitalized Patients in the United States. Clin Infect Dis. 2022. PMID: 34617118. doi:10.1093/cid/ciab696
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。